Frequency and Clinical Relevance of Sarcopenia in Patients with Idiopathic Pulmonary Fibrosis
H Ohkubo, K Fujita, A Nakano, N Takeda, K Fukumitsu… - papers.ssrn.com
Background: Sarcopenia is an age-related syndrome of reduced muscle mass and function
that is well-recognized as a complication in chronic diseases such as chronic obstructive …
that is well-recognized as a complication in chronic diseases such as chronic obstructive …
Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, Y Mori… - Chronic Respiratory …, 2022 - journals.sagepub.com
Objectives Sarcopenia is a syndrome characterized by reduced muscle mass and function. It
is well-recognized as a complication in chronic diseases such as chronic obstructive …
is well-recognized as a complication in chronic diseases such as chronic obstructive …
Prevalence and risk factors of sarcopenia in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
J Li, Y Lu, M Deng, R Tong, Q Zhang, Y Bian… - Frontiers in …, 2023 - frontiersin.org
Background Sarcopenia often occurs as a comorbidity in many diseases which ultimately
affects patient prognosis. However, it has received little attention in patients with idiopathic …
affects patient prognosis. However, it has received little attention in patients with idiopathic …
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
P Faverio, A Fumagalli, S Conti, F Madotto, F Bini… - Respiratory …, 2022 - Springer
Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR)
CM Nolan, M Maddocks, TM Maher, S Patel, RE Barker… - 2020 - Eur Respiratory Soc
Background: Sarcopenia, a clinical syndrome of reduced muscle mass and function, is well-
recognised in chronic disease including COPD. The prevalence of sarcopenia in IPF, and …
recognised in chronic disease including COPD. The prevalence of sarcopenia in IPF, and …
[HTML][HTML] SARC-F scores can predict health status and daily activity in patients with idiopathic pulmonary fibrosis
H Ohkubo, K Fujita, A Nakano, Y Amakusa… - Journal of thoracic …, 2022 - ncbi.nlm.nih.gov
Background The strength, assistance in walking, rising from a chair, climbing stairs, and falls
questionnaire (SARC-F) is widely used for screening sarcopenia. We aimed to examine the …
questionnaire (SARC-F) is widely used for screening sarcopenia. We aimed to examine the …
Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis
Background Sarcopenia, defined using abdominal computed tomography (CT), has been
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …
Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients
Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …
Relationship of Sarcopenia and Frailty in Patients With Outcomes in Idiopathic Pulmonary Fibrosis
M Sridhar, S Bodduluri, L O'Hare… - … TREATMENT OF ILD, 2023 - atsjournals.org
Introduction-Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating lung disease with
variable disease course and high morbidity. Extrapulmonary conditions, including frailty and …
variable disease course and high morbidity. Extrapulmonary conditions, including frailty and …
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
H Ohkubo, K Fujita, A Nakano, N Takeda, K Fukumitsu… - 2022 - europepmc.org
Background: The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
相关搜索
- clinical relevance sarcopenia in patients
- patients with idiopathic pulmonary fibrosis
- clinical outcomes sarcopenia in patients
- frequency and impact sarcopenia in patients
- cause of mortality sarcopenia in patients
- surrogate marker sarcopenia in patients
- muscle mass fibrosis patients
- patients with outcomes relationship of sarcopenia
- patients with outcomes sarcopenia and frailty
- sarcopenia in idiopathic pulmonary fibrosis
- muscle mass impact of sarcopenia
- cause of mortality antifibrotic therapy
- muscle quantification fibrosis patients
- clinical outcomes frequency and impact